CAR-T Without Extracting Patient Cells? J&J Makes $785 Million Bet on In Vivo Therapy
Johnson & Johnson (J&J) is investing more than $785 million (approximately 1.11 trillion won) in next-generation "in vivo CAR-T" technology designed...
Search results for "K-Bio"
More Protein Than Greek Yogurt: 5 Diet-Friendly Foods to Upgrade Your Meal Rotation
Greek yogurt has become one of the most widely discussed high-protein foods in recent years. Favored for weight loss, it offers substantial protein...
AI Tracks Lung Scarring: 4-Percentage-Point Rise in One Year Signals Danger
Researchers have established an artificial intelligence benchmark to quantify the progression of idiopathic pulmonary...
White Frost on Ice Cream: Safe to Eat or Time to Toss?
On a hot summer day, a freezer stocked with ice cream is a welcome comfort. Many people, particularly when eating from...
"Can I Get TAVI, Too?": 11 Key Questions to Ask Before an Aortic Valve Procedure
Many patients with severe aortic valve stenosis delay treatment out of fear of open-heart surgery.
Scalp-Injected RNA Hair Loss Drug Completes Phase 1b Dosing in Australia
OliX announced on August 4 that it has completed patient dosing in the Australian Phase 1b clinical trial for OLX104C...
Daegu Broadens Anti-Aging Focus Beyond Skin to Whole-Body Health
The era of relying solely on cosmetic procedures to maintain youth is fading. Taking its place is "internal...
Timing of Immune Cell Entry Dictates Anti-Cancer Defense in Hard-to-Treat Brain Tumors
Some immune cells surrounding a tumor actively attack it, while others create conditions that help it survive.
Forget Wegovy and Mounjaro: How Hanmi’s 'EPPE' Is Redefining Obesity Care
Hanmi Pharmaceutical has officially named its in-development obesity treatment "EPPE.
Olix Obesity Candidate Reduces Monkeys’ Visceral Fat by 29.2%, Outperforming Global Rival
Olix announced on July 30 that its obesity drug candidate, "OLX501A," significantly outperformed a global rival...